Google News – Oncology External News
Biotechnology Articles
Google News – EMA (biotech/pharma) External News
EMA fast-tracks review of Revolutions' experimental pancreatic cancer pill - ET Pharma
Google News – EMA (biotech/pharma) External News
Latest new meds recommended for approval by EMA’s CHMP - The Pharma Letter
Google News – EMA (biotech/pharma) External News
Teva to acquire Emalex Biosciences - The Pharma Letter
Google News – EMA (biotech/pharma) External News
EU regulator finds no link between GLP-1s and suicidal thoughts - Fierce Pharma
Google News – FDA (biotech/pharma) External News
This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million - Yahoo Finance
Google News – FDA (biotech/pharma) External News
Pharmalittle: We’re reading about FDA commissioner contenders, a heart drug failure, and more - STAT
Google News – FDA (biotech/pharma) External News
Biotech Stock Arcutis Climbs Into Buy Zone As FDA Mulls Expanded Use For Key Skin Treatment - Investor's Business Daily
Google News – FDA (biotech/pharma) External News
FDA Moves Closer to Rule That Could Push Pharma Ads Off Radio - Radio Ink
Google News – FDA (biotech/pharma) External News
FDA Plan Could Put Pharma Ads Out Of Reach For Broadcasters. - Insideradio.com
Google News – FDA (biotech/pharma) External News
Is UroGen Pharma (URGN) Undervalued Following FDA Clearance For UGN 501? - simplywall.st
Google News – FDA (biotech/pharma) External News
H.C. Wainwright reiterates UroGen Pharma stock rating on FDA clearance - Investing.com
Google News – FDA (biotech/pharma) External News
Prime wins Beam arbitration, clearing path to clinic - STAT
Google News – FDA (biotech/pharma) External News
FDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti - Fierce Pharma
Google News – FDA (biotech/pharma) External News